Tumor necrosis factor receptor-associated factor 5 protects against intimal hyperplasia by regulation of macrophage polarization via directly targeting PPARγ

被引:0
|
作者
Cheng, Wen-Lin [1 ,2 ]
Chao, Sheng-ping [1 ,2 ]
Zhao, Fang [1 ,2 ]
Cai, Huan-Huan [1 ,2 ]
Zeng, Ziyue [1 ,2 ]
Cao, Jian-Lei [1 ,2 ]
Jin, Zhili [1 ,2 ]
Deng, Ke-Qiong [1 ,2 ]
Hu, Xiaorong [1 ,2 ]
Wang, Hairong [1 ,2 ]
Lu, Zhibing [1 ,2 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Cardiol, 169 Donghu Rd, Wuhan 430071, Peoples R China
[2] Wuhan Univ, Inst Myocardial Injury & Repair, Wuhan 430071, Peoples R China
基金
中国国家自然科学基金;
关键词
TRAF5; Macrophages; Vascular smooth muscle cell; PPAR gamma; Intimal hyperplasia; MUSCLE-CELL DIFFERENTIATION; TRAF5; ACTIVATION; PATHWAYS; ROLES; PROLIFERATION; INFLAMMATION; RESPONSES; STENTS; MODEL;
D O I
10.1007/s00011-024-01875-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objectives Intimal hyperplasia is a serious clinical problem associated with the failure of therapeutic methods in multiple atherosclerosis-related coronary heart diseases, which are initiated and aggravated by the polarization of infiltrating macrophages. The present study aimed to determine the effect and underlying mechanism by which tumor necrosis factor receptor-associated factor 5 (TRAF5) regulates macrophage polarization during intimal hyperplasia. Methods TRAF5 expression was detected in mouse carotid arteries subjected to wire injury. Bone marrow-derived macrophages, mouse peritoneal macrophages and human myeloid leukemia mononuclear cells were also used to test the expression of TRAF5 in vitro. Bone marrow-derived macrophages upon to LPS or IL-4 stimulation were performed to examine the effect of TRAF5 on macrophage polarization. TRAF5-knockout mice were used to evaluate the effect of TRAF5 on intimal hyperplasia. Results TRAF5 expression gradually decreased during neointima formation in carotid arteries in a time-dependent manner. In addition, the results showed that TRAF5 expression was reduced in classically polarized macrophages (M1) subjected to LPS stimulation but was increased in alternatively polarized macrophages (M2) in response to IL-4 administration, and these changes were demonstrated in three different types of macrophages. An in vitro loss-of-function study with TRAF5 knockdown plasmids or TRAF5-knockout mice revealed high expression of markers associated with M1 macrophages and reduced expression of genes related to M2 macrophages. Subsequently, we incubated vascular smooth muscle cells with conditioned medium of polarized macrophages in which TRAF5 expression had been downregulated or ablated, which promoted the proliferation, migration and dedifferentiation of VSMCs. Mechanistically, TRAF5 knockdown inhibited the activation of anti-inflammatory M2 macrophages by directly inhibiting PPAR gamma expression. More importantly, TRAF5-deficient mice showed significantly aggressive intimal hyperplasia. Conclusions Collectively, this evidence reveals an important role of TRAF5 in the development of intimal hyperplasia through the regulation of macrophage polarization, which provides a promising target for arterial restenosis-related disease management.
引用
收藏
页码:929 / 943
页数:15
相关论文
共 50 条
  • [1] The Cytoprotective Effects of Tumor Necrosis Factor Are Conveyed Through Tumor Necrosis Factor Receptor-Associated Factor 2 in the Heart
    Burchfield, Jana S.
    Dong, Jian-Wen
    Sakata, Yasushi
    Gao, Feng
    Tzeng, Huei-Ping
    Topkara, Veli K.
    Entman, Mark L.
    Sivasubramanian, Natarajan
    Mann, Douglas L.
    CIRCULATION-HEART FAILURE, 2010, 3 (01) : 157 - 164
  • [2] miR-545 promoted enterovirus 71 replication via directly targeting phosphatase and tensin homolog and tumor necrosis factor receptor-associated factor 6
    Sun, Ying
    Feng, Long
    Li, Jiansheng
    Xu, Huaming
    Mei, Xue
    Feng, Lingyan
    Sun, Huijuan
    Gao, Jianfeng
    Zhang, Xiaoli
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 15686 - 15697
  • [3] Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction
    Wang, Lang
    Lu, Yanyun
    Guan, Hongjing
    Jiang, Dingsheng
    Guan, Yu
    Zhang, Xin
    Nakano, Hiroyasu
    Zhou, Yan
    Zhang, Yan
    Yang, Li
    Li, Hongliang
    JOURNAL OF NEUROCHEMISTRY, 2013, 126 (03) : 400 - 414
  • [4] Tumor Necrosis Factor Receptor-Associated Factor 2 Mediates Mitochondrial Autophagy
    Yang, Kai-Chun
    Ma, Xiucui
    Liu, Haiyan
    Murphy, John
    Barger, Philip M.
    Mann, Douglas L.
    Diwan, Abhinav
    CIRCULATION-HEART FAILURE, 2015, 8 (01) : 175 - U309
  • [5] Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis
    Guo, Xiaoyun
    Yin, Haifeng
    Li, Lei
    Chen, Yi
    Li, Jing
    Doan, Jessica
    Steinmetz, Rachel
    Liu, Qinghang
    CIRCULATION, 2017, 136 (08) : 729 - +
  • [6] MicroRNA-127-5p attenuates severe pneumonia via tumor necrosis factor receptor-associated factor 1
    Chen, Cunrong
    Lin, Sen
    Zhou, Lili
    Wang, Jingjing
    Chen, Junnian
    Yu, Ranjie
    Luo, Haoteng
    Lu, Junli
    Xue, Zhiqiang
    Chen, Mingzhi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (03) : 2856 - 2862
  • [7] Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction
    Liu, Wenjuan
    Qi, Yonghao
    Liu, Lingyu
    Tang, Yu
    Wei, Jing
    Zhou, Lijun
    MOLECULAR MEDICINE REPORTS, 2016, 14 (03) : 2171 - 2179
  • [8] Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways
    Shi, Jian-Hong
    Sun, Shao-Cong
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Immune Regulation by TNF Receptor-associated Factor 5
    So, Takanori
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (05): : 489 - 496
  • [10] Immunolocalization of Tumor Necrosis Factor Receptor-Associated Factor 6 in Rat Periapical Lesions
    Yang, Lijie
    Zhang, Chi
    Peng, Bin
    JOURNAL OF ENDODONTICS, 2009, 35 (06) : 834 - 837